Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Yongwei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9670-0922; OpenAlex author ID A5046758084. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Co-author DOI 10.1111/cas.15388↗
  2. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway. Co-author DOI 10.1016/j.bcp.2014.01.041↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bei Sun · 2 shared papers, 2014–2022 · strength 0.16
  2. Shangha Pan · 2 shared papers, 2014–2022 · strength 0.16
  3. Yilong Li · 2 shared papers, 2014–2022 · strength 0.16
  4. Chundong Cheng · 1 shared paper, 2022 · strength 0.13
  5. Gang Wang · 1 shared paper, 2022 · strength 0.13
  6. Hongze Chen · 1 shared paper, 2022 · strength 0.13
  7. Le Li · 1 shared paper, 2022 · strength 0.13
  8. Rui Kong · 1 shared paper, 2022 · strength 0.13
  9. Tao Zhang · 1 shared paper, 2022 · strength 0.13
  10. Zhongjie Zhao · 1 shared paper, 2022 · strength 0.13
  11. Jisheng Hu · 1 shared paper, 2022 · strength 0.13
  12. Danxi Liu · 1 shared paper, 2022 · strength 0.13
  13. Zonglin Liu · 1 shared paper, 2022 · strength 0.13
  14. Zengfu Song · 1 shared paper, 2014 · strength 0.04
  15. Hongchi Jiang · 1 shared paper, 2014 · strength 0.04
  16. Guang Jia · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.